SEC Form 4 · accession 0001179110-18-014135
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael T. Andriole
Officer — Chief Financial Officer
Period of report
Dec 17, 2018
Accepted (ET)
Dec 19, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2018 | M | 25,000 | $2.22 | A | 157,082 | D | |
| Common StockF1 | Dec 17, 2018 | G | 4,500 | $0.00 | D | 152,582 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $2.22 | Dec 17, 2018 | M | 25,000 | D | — | Feb 20, 2027 | Common Stock | 25,000 | 75,000 | D |
Explanation of responses
- F1Represents a gift of 4,500 shares to a donor advised fund.
- F2Shares subject to this option vest 1/4 annually over a period of four years beginning February 20, 2018.